Towards an understanding of amyloid-β oligomers: characterization, toxicity mechanisms, and inhibitors
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
This review illustrates the recent understanding of amyloid-β oligomers' characteristics and toxicity-related pathways, along with inhibitors against Aβ aggregation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aβ plaques are accumulations of sticky Aβ peptides outside of the neurons and impede the synaptic communication between neurons, leading to neuronal death.”
From Primary Cilia and Cardiovascular Risk Factors in Alzheimer's Disease (2025) · cites this paper as [3]
In the citing paper
“Aβ peptides are formed by proteolytic cleavage of the amyloid precursor protein (APP), specifically the hydrophobic transmembrane portion, by β- and γ-secretases [3].”
From Primary Cilia and Cardiovascular Risk Factors in Alzheimer's Disease (2025) · cites this paper as [3]
In the citing paper
“Soluble Aβ oligomers are the primary neurotoxic substances,131–133”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [133]
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769
RetractedAlzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Protein Misfolding, Functional Amyloid, and Human Disease
Chiti, F., & Dobson, C. M. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.101304.123901 · Cited by 6,423
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism
Cohen, S. I. A., Linse, S., Luheshi, L. M., Hellstrand, E., White, D. A., Rajah, L., Otzen, D. E., Vendruscolo, M., Dobson, C. M., & Knowles, T. P. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218402110 · Cited by 1,440
EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
Ehrnhoefer, D. E., Bieschke, J., Boeddrich, A., Herbst, M., Masino, L., Lurz, R., Engemann, S., Pastore, A., & Wanker, E. E. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1437 · Cited by 1,434
Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models
Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G.-Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. C., Nicoll, R. A., & Mucke, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3228 · Cited by 1,123
Cited by
Items 201–300 of 577
Yu, Z., Guo, W., Patel, S., Cho, H., Sun, L., & Mirica, L. M. (2022) · Chemical Science · doi:10.1039/d2sc02654f · Cited by 28
Li, Y., Yu, K.-Y., Cui, Y., Wang, Z.-J., Cai, H.-Y., Cao, J., & Wu, M. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.01.008 · Cited by 24
Sarkar, D., Chakraborty, I., Condorelli, M., Ghosh, B., Mass, T., Weingarth, M. H., Mandal, A. K., Rosa, C. L., Vivekanandan, S., & Bhunia, A. (2019) · ChemMedChem · doi:10.1002/cmdc.201900620 · Cited by 23
AFM Probing of Amyloid-Beta 42 Dimers and Trimers
Maity, S., & Lyubchenko, Y. L. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00069 · Cited by 25
Ge, Y., Zeng, F., Sun, G., Peng, K., Li, X., Yu, H., Cheng, C., Xu, Y., & Yang, J. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00419 · Cited by 23
Malishev, R., Nandi, S., Śmiłowicz, D., Bakavayev, S., Engel, S., Bujanover, N., Gazit, R., Metzler‐Nolte, N., & Jelinek, R. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00177 · Cited by 22
Wu, J., Dong, W., Zhang, Z., Liu, J., Akioma, M., Liu, J., Liu, Y., Pliss, A., Zhang, X., & Luan, P. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101284 · Cited by 22
Yawson, G. K., Will, M. F., Huffman, S. E., Strandquist, E. T., Bothwell, P. J., Oliver, E. B., Apuzzo, C. F., Platt, D. C., Weitzel, C. S., Jones, M. A., et al. (2022) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.1c01651 · Cited by 24
Li, W., Gao, J.-Y., Lin, S.-Y., Pan, S.-T., Xiao, B., Ma, Y.-T., Xie, K., Shen, W., Liu, Z.-T., Li, G.-Y., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02784-9 · Cited by 25
Hong, M., Kim, M., Yoon, J., Lee, S., Baik, M., & Lim, M. H. (2022) · JACS Au · doi:10.1021/jacsau.2c00281 · Cited by 22
Self-citationJohn, T., Martin, L. L., & Abel, B. (2023) · Macromolecular Bioscience · doi:10.1002/mabi.202200576 · Cited by 22
Advanced analytical methodologies in Alzheimer’s disease drug discovery
Simone, A. D., Naldi, M., Tedesco, D., Bartolini, M., Davani, L., & Andrisano, V. (2019) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2019.112899 · Cited by 22
Toward the Mode of Action of the Clinical Stage All- d -Enantiomeric Peptide RD2 on Aβ42 Aggregation
Zhang, T., Gering, I., Kutzsche, J., Nagel‐Steger, L., & Willbold, D. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00458 · Cited by 24
The Beneficial Role of Natural Endocrine Disruptors: Phytoestrogens in Alzheimer’s Disease
Domańska, A., Orzechowski, A., Litwiniuk, A., Kalisz, M., Bik, W., & Baranowska-Bik, A. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/3961445 · Cited by 28
“Neuroprotective effects in vivo were also observed with γ-mangostin (γ-M), originally isolated from Garcinia mangostana tree [94] and glabridin (GLA) isolated from the roots of Glycyrrhiza glabra L.”
BackgroundKim, S., Nam, Y., Shin, S. J., Prajapati, R., Shin, S. M., Kim, M., Kim, H. S., Leem, S. H., Kim, T., Park, Y., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113865 · Cited by 23
Zhao, B., Wei, D., Long, Q., Chen, Q., Wang, F., Chen, L., Li, Z., Li, T., Ma, T., Liu, W., et al. (2023) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2023.10.006 · Cited by 25
“A b production is related to a - secretase (ADAM10), BACE1, PS1 and IDE [61,62].”
BackgroundKim, M., Gupta, G., Lee, J., Na, C., Kwak, J., Lin, Y., Lee, Y., Lim, M. H., & Lee, C. Y. (2024) · Inorganic Chemistry Frontiers · doi:10.1039/d3qi02445h · Cited by 21
Self-citationPlasma Biomarkers: Potent Screeners of Alzheimer’s Disease
Naveed, M., Mubeen, S., Khan, A., Ibrahim, S., & Meer, B. (2019) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317519848239 · Cited by 27
Wang, Z., Gao, C., Zhang, L., & Sui, R. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01476-1 · Cited by 20
“In order to understand how misfolded entities give toxicity, it is crucial to understand their toxic traits (Lee et al. 2017).”
Artificial Chiral Interfaces against Amyloid-β Peptide Aggregation: Research Progress and Challenges
Zhou, Z., Gu, Y., & Wang, H. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00544 · Cited by 21
Hypoxia and the Kynurenine Pathway: Implications and Therapeutic Prospects in Alzheimer’s Disease
Adeyemı, O. S., Awakan, O. J., Afolabi, B., Rotimi, D. E., Oluwayemi, E. T., Otuechere, C. A., Ibraheem, O., Elebiyo, T. C., Alejolowo, O. O., & Arowolo, A. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5522981 · Cited by 21
“The Aβ oligomers trigger proinflammatory cascades, oxidative stress and mitochondrial impairment, induction of neuronal apoptosis, increased phosphorylation of tau proteins, deregulation of calcium metabolism, and cell death by interacting with neurons and glial cells (Figure 2) [42], making them the most toxic of all…”
BackgroundCui, W.-B., Zhang, Z., Bai, X., Wang, S., Chen, X., Liu, X., Su, P., Zhi, D., Fei, D., Zhang, Z., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710030 · Cited by 22
“Among them, Aβ oligomers are considered to be the main toxic components [7], and the fibrils can also act as a reservoir of toxic oligomers through fracture and secondary nucleation [14].”
BackgroundMethods for analyzing the coordination and aggregation of metal–amyloid-β
Park, S., Na, C., Han, J., & Lim, M. H. (2023) · Metallomics · doi:10.1093/mtomcs/mfac102 · Cited by 20
Self-citationAmyloid β structural polymorphism, associated toxicity and therapeutic strategies
Oren, O., Taube, R., & Papo, N. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03954-z · Cited by 22
Pomier, K. M., Ahmed, R., & Melacini, G. (2021) · Biophysical Chemistry · doi:10.1016/j.bpc.2021.106743 · Cited by 22
Strategic Design of 2,2′-Bipyridine Derivatives to Modulate Metal–Amyloid-β Aggregation
Ji, Y., Lee, H. J., Kim, M., Nam, G., Lee, S. J. C., Cho, J., Park, C., & Lim, M. H. (2017) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.7b00782 · Cited by 25
Self-citationLee, H. J., Lee, Y. G., Kang, J., Yang, S. H., Kim, J. H., Ghisaidoobe, A. B. T., Kang, H. J., Lee, S., Lim, M. H., & Chung, S. J. (2018) · Chemical Science · doi:10.1039/c8sc04943b · Cited by 20
Self-citationInterference with Amyloid-β Nucleation by Transient Ligand Interaction
Zhang, T., Loschwitz, J., Strodel, B., Nagel‐Steger, L., & Willbold, D. (2019) · Molecules · doi:10.3390/molecules24112129 · Cited by 18
Spiegel, M., Marino, T., Prejanò, M., & Russo, N. (2022) · Physical Chemistry Chemical Physics · doi:10.1039/d2cp01918c · Cited by 19
Huang, L., Zeng, Y., Li, Y., Zhu, Y., He, Y., Liu, Y., Robert, A., & Meunier, B. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122691 · Cited by 19
“Copper complexes of β-amyloid short oligomers, able to penetrate neurons, might trigger this oxidative stress within different neuronal sub-compartments [12].”
BackgroundRecent developments in the chemical biology of amyloid-β oligomer targeting
Wang, Y., Chen, J., Gao, F., Hu, M., & Wang, X. (2023) · Organic & Biomolecular Chemistry · doi:10.1039/d3ob00509g · Cited by 21
Ding, J., Luo, W., Wu, T., Cai, S., Pan, Z., Li, H., Tu, B., Fang, Q., Yan, X., & Yang, R. (2023) · Nano Today · doi:10.1016/j.nantod.2023.102121 · Cited by 19
Liu, L., Liu, W., Sun, Y. P., & Dong, X. (2024) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2024.05.193 · Cited by 22
Gao, K.-X., Zhou, Z., Yao, L., Wang, S., Zhang, Y., Zou, Q., Ma, L., & Wang, H. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.1c01245 · Cited by 19
Unveiling the Effects of Copper Ions in the Aggregation of Amyloidogenic Proteins
Oliveri, V. (2023) · Molecules · doi:10.3390/molecules28186446 · Cited by 22
“Soluble oligomers are currently considered the most toxic species and cause toxicity by interacting with lipid rafts and synaptic receptors on cellular membranes [67,68].”
Amyloid‐β in Alzheimer's disease: Structure, toxicity, distribution, treatment, and prospects
Yu, Y., Yu, S., Battaglia, G., & Tian, X. (2024) · Ibrain · doi:10.1002/ibra.12155 · Cited by 38
“In the nonamyloid hydrolytic [13]”
BackgroundZhang, X., Hou, Y., Peng, C., Wang, C., Wang, X., Liang, Z., Lu, J. N., Chen, B., Dai, J., Liu, B., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01834 · Cited by 18
Yuan, C., Duan, W., Luo, J. H., Han, Y., & Wang, X. (2020) · Chemical Communications · doi:10.1039/d0cc01384f · Cited by 19
Isomeric Effect of Nano-Inhibitors on Aβ40 Fibrillation at The Nano-Bio Interface
Li, J., Gao, G., Tang, X., Yu, M. S., He, M. X., & Sun, T. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c21906 · Cited by 18
Shityakov, S., Hayashi, K., Störk, S., Scheper, V., Lenarz, T., & Förster, C. Y. (2021) · Biomolecules · doi:10.3390/biom11060900 · Cited by 20
“The pathological process in AD is based on the formation of amyloid fibrils (Aβ) and amyloid oligomers, which have to be explored to inhibit the Aβ aggregation process more efficiently [95,96].”
BackgroundJin, Z., Lu, Y., Tang, H., & Cui, H. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70472 · Cited by 27
Amyloid Beta in Alzheimer's Disease: Mechanisms, Biomarker Potential, and Therapeutic Targets
Ahmadi, S., Khaledi, S., Ahmadi, K., & Hassanzadeh, K. (2025) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.70688 · Cited by 22
“The resulting impairment of calcium signaling initiates a degenerative cascade culminating in spine shrinkage and synaptic dysfunction [114] (Figure 6).”
Sun, R., Wang, Z., Zhao, J., Wang, S., Liu, Y., Liu, S., Li, Z., & Wang, X. (2021) · The Anatomical Record · doi:10.1002/ar.24737 · Cited by 20
Contribution of hyperglycemia-induced changes in microglia to Alzheimer’s disease pathology
Rodríguez, M. H., Flores‐Clemente, C., Macías-Pérez, M. E., Rodríguez-Fonseca, R. A., Nicolás‐Vázquez, M. I., Martínez, J. O., Miranda, R., Rosas, M., & Jiménez, E. M. (2022) · Pharmacological Reports · doi:10.1007/s43440-022-00405-9 · Cited by 19
“oAβs exert their toxic effects at several levels by binding to cell membranes, receptors, and organelles, thus impairing function and altering signaling pathways [6].”
BackgroundBerntsson, E., Vosough, F., Svantesson, T., Pansieri, J., Iashchishyn, I. A., Ostojić, L., Dong, X., Paul, S., Jarvet, J., Roos, P. M., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-29901-5 · Cited by 18
Hawkins, K., & Duchen, M. R. (2019) · World Journal of Stem Cells · doi:10.4252/wjsc.v11.i5.236 · Cited by 18
Li, Y., Nguyen, M., Baudoin, M., Vendier, L., Liu, Y., Robert, A., & Meunier, B. (2019) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.201900951 · Cited by 17
Rana, M., Pareek, A., Bhardwaj, S., Arya, G., Nimesh, S., Arya, H., Bhatt, T. K., Yaragorla, S., & Sharma, A. K. (2020) · RSC Advances · doi:10.1039/d0ra05172a · Cited by 17
Magro, R. D., Vitali, A., Fagioli, S., Casu, A., Falqui, A., Formicola, B., Taiarol, L., Cassina, V., Marrano, C. A., Mantegazza, F., et al. (2021) · Antioxidants · doi:10.3390/antiox10020266 · Cited by 17
Keggin-type polyoxometalates as Cu( ii ) chelators in the context of Alzheimer's disease
Atrián‐Blasco, E., de Cremoux, L., Lin, X., Mitchell‐Heggs, R., Sabater, L., Blanchard, S., & Hureau, C. (2022) · Chemical Communications · doi:10.1039/d1cc05792h · Cited by 18
Targeting the Intrinsically Disordered Proteome Using Small-Molecule Ligands
Wojcik, S. P., Birol, M., Rhoades, E. R., Miranker, A. D., & Levine, Z. A. (2018) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2018.09.036 · Cited by 18
Asadbegi, M., & Shamloo, A. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00468 · Cited by 16
Zakharova, N. V., Bugrova, A. E., Kononikhin, A. S., Indeykina, M. I., Popov, I. A., & Николаев, Е. Н. (2018) · Expert Review of Proteomics · doi:10.1080/14789450.2018.1525296 · Cited by 17
Necessity of regulatory guidelines for the development of amyloid based biomaterials
Kumar, V., Sinha, N., & Thakur, A. K. (2021) · Biomaterials Science · doi:10.1039/d1bm00059d · Cited by 16
Structural determinants of the interactions of catechins with Aβ oligomers and lipid membranes
Ahmed, R., Huang, J., Lifshitz, R., Pomier, K. M., & Melacini, G. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101502 · Cited by 15
“One of the key mechanisms by which oligomers confer toxicity is through disrupting the integrity of biological membranes (3).”
BackgroundZhang, Z., Bai, X., Cui, W.-B., Chen, X., Liu, X., Zhi, D., Zhang, Z., Fei, D., & Wang, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126871 · Cited by 16
“Among them, oligomers are considered to be more toxic than monomers and fibrils [17].”
BackgroundOxidative Damages on the Alzheimer’s Related-Aβ Peptide Alters Its Ability to Assemble
Cheignon, C., Collin, F., Sabater, L., & Hureau, C. (2023) · Antioxidants · doi:10.3390/antiox12020472 · Cited by 19
Liquid–liquid phase separation induced by crowding condition affects amyloid-β aggregation mechanism
Kobayashi, R., & Nabika, H. (2024) · Soft Matter · doi:10.1039/d4sm00470a · Cited by 16
Liu, H., Li, Y., Wei, L., Ye, Z., Yuan, J., & Xiao, L. (2024) · Nano Today · doi:10.1016/j.nantod.2024.102434 · Cited by 16
Gehlot, P., Pathak, R., Kumar, S., Choudhary, N. K., & Vyas, V. K. (2024) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2024.117925 · Cited by 20
Trusova, V., & Gorbenko, G. (2018) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2017.1349691 · Cited by 14
Intertwined Pathologies of Amyloid-β and Metal Ions in Alzheimer’s Disease: Metal–Amyloid-β
Nam, G., & Lim, M.-H. (2019) · Chemistry Letters · doi:10.1246/cl.190281 · Cited by 12
Self-citationAhmed, R., Huang, J., Akimoto, M., Shi, T., & Melacini, G. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.0c13289 · Cited by 16
Chakraborty, I., Kar, R. K., Sarkar, D., Kumar, S., Maiti, N. C., Mandal, A. K., & Bhunia, A. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00262 · Cited by 16
Mass spectrometric studies of the variety of beta‐amyloid proteoforms in Alzheimer's disease
Zakharova, N. V., Kononikhin, A. S., Indeykina, M. I., Bugrova, A. E., Strelnikova, P. A., Игоревич, П. С., Kozin, S. A., Popov, I. A., Mitkevich, V. A., Makarov, A. А., et al. (2022) · Mass Spectrometry Reviews · doi:10.1002/mas.21775 · Cited by 20
“…(A β ) in the brain (Wang et al., 2017), and for ~30 years the formation of amyloid oligomers and plaques has been considered the key pathological change causing fatal neuronal destruction (Hardy & Higgins, 1992; Klein et al., 2001; Lee et al., 2017; Roher et al., 1993a; Selkoe & Hardy, 2016).”
Bi, A., Wang, Y., Chen, L., Yin, Z., & Luo, L. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110019 · Cited by 17
Synthesis and effects of flavonoid structure variation on amyloid-β aggregation
de Matos, A. M., Cristóvão, J. S., Yashunsky, D. V., Nifantiev, N. E., Viana, A. S., Gomes, C. M., & Rauter, A. P. (2017) · Pure and Applied Chemistry · doi:10.1515/pac-2017-0201 · Cited by 17
Bao, L., Hao, S., Xi, S., Yan, X., Zhang, H., Shen, R., & Gu, Z. (2018) · Chemical Communications · doi:10.1039/c8cc04913k · Cited by 17
Force clamp approach for characterization of nano-assembly in amyloid beta 42 dimer
Maity, S., & Lyubchenko, Y. L. (2019) · Nanoscale · doi:10.1039/c9nr01670h · Cited by 16
Cong, S., Shi, Y., Yu, G., Zhong, F., Li, J., Liu, J., Ye, C., Tan, Z., & Deng, Y. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115216 · Cited by 15
New Insights into Alzheimer’s Disease: Novel Pathogenesis, Drug Target and Delivery
Chen, H., Xu, J., Xu, H., Luo, T., Li, Y., Jiang, K., Shentu, Y., & Tong, Z. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041133 · Cited by 17
“Drugs Used to Prevent Aβ Aggregation Since non-toxic Aβ monomers aggregate to form neurotoxic AβO and SPs [87], some drugs have been established to prevent Aβ aggregation (Table 2).”
BackgroundInfluentialDu, Z., Nam, E., Lin, Y., Hong, M., Molnár, T., Kondo, I., Ishimori, K., Baik, M., Lee, Y., & Lim, M. H. (2023) · Chemical Science · doi:10.1039/d3sc00881a · Cited by 17
Self-citationCritical aggregation concentration and reversibility of amyloid-β (1–40) oligomers
Illodo, S., Al‐Soufi, W., & Novo, M. (2024) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2024.110179 · Cited by 17
Heo, C. E., Choi, T. S., & Kim, H. I. (2018) · International Journal of Mass Spectrometry · doi:10.1016/j.ijms.2018.02.002 · Cited by 17
Oren, O., Banerjee, V., Taube, R., & Papo, N. (2018) · Biochemical Journal · doi:10.1042/bcj20180247 · Cited by 15
Rational Design of a Cocktail of Inhibitors against Aβ Aggregation
Gao, L., Yang, W., Li, W., Luo, Y.-Y., Lim, Y., Li, Y., Paul, A., Segal, D., Hong, L., & Li, Y. (2020) · Chemistry - A European Journal · doi:10.1002/chem.201905621 · Cited by 15
Chemical control of peptide material phase transitions
Tan, J., Zhang, L., Hsieh, M.-C., Goodwin, J. T., Grover, M. A., & Lynn, D. G. (2021) · Chemical Science · doi:10.1039/d0sc03666h · Cited by 14
Gao, L., Zhou, Y., Yang, W., Zhang, C., Hong, L., & Jia, L. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00223 · Cited by 16
Chiral effect on Aβ fibrillation from molecular-scale to nanoscale
Gao, G., Zhu, G., Yu, L., Zhang, Z., Zhang, T., Liu, X., Zhang, C., Zhou, L. P., & Sun, T. (2022) · Nano Research · doi:10.1007/s12274-022-4303-9 · Cited by 16
Zimbone, S., Giuffrida, M. L., Sabatino, G., Natale, G. D., Tosto, R., Consoli, G. M. L., Milardi, D., Pappalardo, G., & Sciacca, M. F. M. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00720 · Cited by 16
A near-infrared fluorescent probe for amyloid-β aggregates
Lee, M., Kim, M., Tikum, A. F., Lee, H. J., Thamilarasan, V., Lim, M. H., & Kim, J. (2018) · Dyes and Pigments · doi:10.1016/j.dyepig.2018.10.013 · Cited by 17
Self-citationKIBRA regulates amyloid β metabolism by controlling extracellular vesicles secretion
Han, X., Wang, C., Song, L., Wang, X., Tang, S. H., Hou, T., Liu, C., Liang, X., Qiu, C., Wang, Y., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103980 · Cited by 15
Systems Biology to Address Unmet Medical Needs in Neurological Disorders
Savelieff, M. G., Noureldein, M. H., & Feldman, E. L. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2265-0_13 · Cited by 15
Self-citationRed emissive fluorescent carbon dots based on ternary carbon source for imaging α-synuclein fibrils.
Zhang, J., Luo, W., Zhang, Y., Li, X., Jiang, M., Huang, K., Yu, X., & Xu, L. (2024) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2024.05.129 · Cited by 12
Etersalate prevents the formations of 6Aβ16-22 oligomer: An in silico study
Ngô, S. T., Luu, X., Nguyen, N. T., Vu, V. V., & Phùng, H. T. T. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204026 · Cited by 14
Park, S., Yi, Y., & Lim, M. H. (2020) · Bulletin of the Korean Chemical Society · doi:10.1002/bkcs.12172 · Cited by 16
Self-citationThe role of alpha-helix on the structure-targeting drug design of amyloidogenic proteins
Tempra, C., Rosa, C. L., & Lolicato, F. (2021) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2021.105061 · Cited by 19
Lipid membranes induce structural conversion from amyloid oligomers to fibrils
Gu, L., & Guo, Z. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.03.174 · Cited by 16
Kim, M., & Lim, M. H. (2021) · Bulletin of the Korean Chemical Society · doi:10.1002/bkcs.12372 · Cited by 14
Self-citationBugrova, A. E., Strelnikova, P. A., Indeykina, M. I., Kononikhin, A. S., Zakharova, N. V., Brzhozovskiy, A. G., Barykin, E. P., Игоревич, П. С., Gavrish, M. S., Babaev, A. A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010027 · Cited by 18
Mallesh, R., Khan, J., Gharai, P. K., Ghosh, S., Garg, S., Arshi, M. U., & Ghosh, S. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00787 · Cited by 15
Kim, S., Lee, H. J., Nam, E., Jeong, D., Cho, J., Lim, M. H., & You, Y. (2018) · ACS Omega · doi:10.1021/acsomega.8b00286 · Cited by 16
Self-citationHou, T., Nie, D., Ding, M., Wang, C., Mei, K., Lu, X., Wang, X., Tang, S., Wu, H. Y., Guan, P., et al. (2025) · Journal of Material Science and Technology · doi:10.1016/j.jmst.2025.04.081 · Cited by 13
Qiu, Y., Yang, J., Ma, L., Song, M., & Liu, G. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.879028 · Cited by 17
Rational design of photoactivatable metal complexes to target and modulate amyloid-β peptides
Kwak, J., Woo, J., Park, S., & Lim, M. H. (2022) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2022.112053 · Cited by 16
Self-citationLeng, H., Yang, J., Long, L., Yan, Y., Shi, W., Zhang, L., & Yan, J. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106540 · Cited by 14
Fluorescent Sensing Platforms for Detecting and Imaging the Biomarkers of Alzheimer’s Disease
Liu, X., Liu, Y., & Liu, Q. (2023) · Biosensors · doi:10.3390/bios13050515 · Cited by 13
“Therefore, Aβ (including Aβ monomers, oligomers and plaques) [17,25,26] and tau (including total tau proteins and phosphorylated tau proteins) [9,20,27] are generally regarded as the two most important types of AD biomarkers in blood.”
BackgroundSong, X., Wang, C., Ding, Q., Li, P., Sun, S., Wei, W., Zhang, J., Sun, R., Yin, L., Liu, S., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.12.060 · Cited by 16
Atomistic investigation of an Iowa Amyloid-β trimer in aqueous solution
Ngô, S. T., Phùng, H. T. T., Vu, K. B., & Vu, V. V. (2018) · RSC Advances · doi:10.1039/c8ra07615d · Cited by 13
Binary Structure of Amyloid Beta Oligomers Revealed by Dual Recognition Mapping
Yoon, J., Kim, Y., & Park, J. W. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b01316 · Cited by 13
Metadata
- Authors
- Lee, S. J. C., Nam, E., Lee, H. J., Savelieff, M. G., & Lim, M. H.
- Affiliations
- Ulsan National Institute of Science and Technology (KR)
- University of Michigan (US)
- Corresponding author
- Lim, Mi Hee
- Venue
- Chemical Society Reviews
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2017
- Volume
- 46
- Issue
- 2
- Pages
- 310-323
- ISSN
- 0306-0012 (ISSN-L)
- 1460-4744
- OpenAlex
- W2550762885
- Cited by
- 576
- References
- 51
- Citations by year
- 2026: 38 · 2025: 69 · 2024: 72 · 2023: 75 · 2022: 66 · 2021: 78 · 2020: 60 · 2019: 54 · 2018: 45 · 2017: 18
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Chemical Society Reviews (publishedVersion)
- PubMed (publishedVersion)
- Scholarworks@UNIST (Ulsan National Institute of Science and Technology) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta oligomers, Alzheimer's disease, amyloid-beta aggregation, amyloid fibril formation, amyloidosis, amyloid-beta clearance
- MeSH terms
- Alzheimer Disease, Humans, Amyloid beta-Peptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.